Carlsmed Inc (CARL)

EBITDA Growth

-3.15%

TTM · Period ending:

CARL logo

CARL EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-3.15%
CARL TTM EBITDA YoY % (1.83% → -3.15%)
High-resolution chart · PNG

CARL ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Carlsmed Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-3.1468%
-32.525%
-20.0679%
1.8252%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.